3-(4-Methylphenyl)-1,2-oxazole-5-carboxylic acid, 95%, 500mg

N-Boc-5-Hydroxyindoline, 97.0%, 1g

5-Fluoro-2-iodobenzotrifluoride, 95.0%, 25g

3-BROMO-2-CHLOROBENZYL ALCOHOL, 95.0%, 1g

7,8,9,10-Tetrahydro-benzo[a]pyren-7-ol, 98.0%, 1g

2-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 98+%, 1g

Mono-potassium citrate, min. 99%, pure, anhydrous, 500 g, plastic packaging.

SRC KINASE INHIBITOR I, 95%, 250mg

(2-Amino-thiazol-5-yl)-acetic acid methyl ester hydrobromide, 95.0%, 1g

N-(6-BROMO-2,3-DIHYDRO-1H-INDEN-5-YL)ACETAMIDE, 97.0%, 5g

Methyl 6-iodonicotinate, 95.0%, 10g

2-ETHYLPHENANTHRENE, 95%, 1g

1-(3-methoxybenzoyl)piperazine hydrochloride, 95.0%, 25g